×
For best experience we recommend to activate Javascript in your browser.
IRAK3 antibody (AA 454-596)
The Mouse Monoclonal anti-IRAK3 antibody (ABIN5902350) specifically detects IRAK3 in WB, ELISA, IHC, IF/ICC and FACS.
The antibody is reactive with Human samples.
Catalog No. ABIN5902350
$572.76
Plus shipping costs $50.00
Delivery in 10 to 18 Business Days
Quick Overview for IRAK3 antibody (AA 454-596) (ABIN5902350)
Target
See all IRAK3 Antibodies
IRAK3
(Interleukin-1 Receptor-Associated Kinase 3 (IRAK3))
Reactivity
All reactivities for IRAK3 antibodies
Human
Host
All hosts for IRAK3 antibodies
Mouse
Clonality
All clonalities for IRAK3 antibodies
Monoclonal
Conjugate
All conjugates for IRAK3 antibodies
This IRAK3 antibody is un-conjugated
Application
All applications for IRAK3 antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (fixed cells) (IF/ICC), Flow Cytometry (FACS)
Product Details anti-IRAK3 Antibody
(hide)
Binding Specificity
All epitopes for IRAK3 antibodies
AA 454-596
Purification
Purified antibody
Immunogen
Purified recombinant fragment of human IRAK3 (AA: 454-596) expressed in E. Coli.
Isotype
IgG1
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1.0 mg/mL
Buffer
Purified antibody in PBS with 0.05 % sodium azide
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Target Details for IRAK3
(hide)
Target
IRAK3
(Interleukin-1 Receptor-Associated Kinase 3 (IRAK3))
Alternative Name
IRAK3
Molecular Weight
67.8 kDa
Gene ID
11213
UniProt
Q9Y616
Pathways
TLR Signaling , Activation of Innate immune Response , Production of Molecular Mediator of Immune Response , Toll-Like Receptors Cascades
Recently viewed
(hide)
Chat with us , powered by LiveChat